Raphael Nir
Fondateur chez Vuja De Sciences, Inc.
Profil
Raphael Nir is the founder of Alma Bio Therapeutics, SBH Sciences, Inc., Sky Ventures International LLC, NeuroDex, Inc., and Abi-Lab2 LLC.
Alma Bio Therapeutics was founded in 2014, SBH Sciences, Inc. was founded in 1997, Sky Ventures International LLC was founded in 2014, NeuroDex, Inc. was founded in 2018, and Abi-Lab2 LLC was founded in 2016.
Dr. Nir's titles held at SBH Sciences, Inc. include President and CSO.
Dr. Nir is also the founder of Vuja De Sciences, Inc. Dr. Nir received a doctorate degree from Tel-Aviv University in 1990 and a graduate degree from New Jersey Institute of Technology in 1997.
Postes actifs de Raphael Nir
| Sociétés | Poste | Début |
|---|---|---|
Vuja De Sciences, Inc.
 Vuja De Sciences, Inc. Pharmaceuticals: MajorHealth Technology Vuja De Sciences, Inc. is engaged in biotechnology services. The company was founded by David Warshawsky, Rick Lampe, Robert E. Hurst and Raphael Nir and is headquartered in Hoboken, NJ. | Fondateur | - |
NeuroDex, Inc.
 NeuroDex, Inc. Miscellaneous Commercial ServicesCommercial Services NeuroDex, Inc. engages in the development of a research platform focuses on diagnostics, theranostics, prognostics, and pharmacodynamic analysis. It offers ExoSORT that combines bioinformatics and state-of-the-art laboratory processes. The company was founded by Erez Eitan and Oded Biran in 2018 and is headquartered in Arlington, MA. | Fondateur | 01/08/2018 |
| Abi-Lab2 LLC | Fondateur | 01/02/2016 |
Alma Bio Therapeutics
 Alma Bio Therapeutics Miscellaneous Commercial ServicesCommercial Services Alma Bio Therapeutics is a French company that aims to restore immune resilience in patients suffering from autoimmune diseases. The private company's therapeutic approach employs the language of the immune system to improve patients' health by targeting the underlying cause of the disease. The company's treatment aims to support the immune system rather than suppressing it, restoring its natural resilience and providing improved safety and an opportunity for durable remission. Alma Bio Therapeutics has developed a breakthrough therapy that is targeted, specific, and confined to the site of disease, reinstating immune balance with no overdrive or complete suppression. The company's platform-technology is applicable to several autoimmune diseases, promising to yield a versatile pipeline. The company's lead programs are directed towards diseases of complex etiology in areas of significant unmet clinical need, with inflammatory bowel disease (IBD) as their first clinical indication. Alma Bio Therapeutics is led by a seasoned management team with extensive expertise in business development, drug development, and technology commercialization. | Fondateur | 01/05/2014 |
SBH Sciences, Inc.
 SBH Sciences, Inc. BiotechnologyHealth Technology SBH Sciences, Inc. offers biotechnology products and services for discovery research. The private company is based in Natick, MA. The company support startup companies, entrepreneur scientists, and the biotechnology industry to helps shorten timelines and reduce costs. The company also provides precise and reliable biomarker evaluations for veterinary and in vivo studies of rats, pigs, equines, and canines. | Fondateur | 01/09/1997 |
Anciens postes connus de Raphael Nir
| Sociétés | Poste | Fin |
|---|---|---|
Sky Ventures International LLC
 Sky Ventures International LLC Investment ManagersFinance Sky Ventures International LLC (Sky Ventures) is a venture capital firm founded in 2015 by Eyal Geffen and Raphael Nir. The firm is headquartered in Boston, Massachusetts. | Fondateur | 31/12/2016 |
Formation de Raphael Nir
| Tel-Aviv University | Doctorate Degree |
| New Jersey Institute of Technology | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
SBH Sciences, Inc.
SBH Sciences, Inc. BiotechnologyHealth Technology SBH Sciences, Inc. offers biotechnology products and services for discovery research. The private company is based in Natick, MA. The company support startup companies, entrepreneur scientists, and the biotechnology industry to helps shorten timelines and reduce costs. The company also provides precise and reliable biomarker evaluations for veterinary and in vivo studies of rats, pigs, equines, and canines. | Health Technology |
Vuja De Sciences, Inc.
Vuja De Sciences, Inc. Pharmaceuticals: MajorHealth Technology Vuja De Sciences, Inc. is engaged in biotechnology services. The company was founded by David Warshawsky, Rick Lampe, Robert E. Hurst and Raphael Nir and is headquartered in Hoboken, NJ. | Health Technology |
Sky Ventures International LLC
Sky Ventures International LLC Investment ManagersFinance Sky Ventures International LLC (Sky Ventures) is a venture capital firm founded in 2015 by Eyal Geffen and Raphael Nir. The firm is headquartered in Boston, Massachusetts. | Finance |
NeuroDex, Inc.
NeuroDex, Inc. Miscellaneous Commercial ServicesCommercial Services NeuroDex, Inc. engages in the development of a research platform focuses on diagnostics, theranostics, prognostics, and pharmacodynamic analysis. It offers ExoSORT that combines bioinformatics and state-of-the-art laboratory processes. The company was founded by Erez Eitan and Oded Biran in 2018 and is headquartered in Arlington, MA. | Commercial Services |
Alma Bio Therapeutics
Alma Bio Therapeutics Miscellaneous Commercial ServicesCommercial Services Alma Bio Therapeutics is a French company that aims to restore immune resilience in patients suffering from autoimmune diseases. The private company's therapeutic approach employs the language of the immune system to improve patients' health by targeting the underlying cause of the disease. The company's treatment aims to support the immune system rather than suppressing it, restoring its natural resilience and providing improved safety and an opportunity for durable remission. Alma Bio Therapeutics has developed a breakthrough therapy that is targeted, specific, and confined to the site of disease, reinstating immune balance with no overdrive or complete suppression. The company's platform-technology is applicable to several autoimmune diseases, promising to yield a versatile pipeline. The company's lead programs are directed towards diseases of complex etiology in areas of significant unmet clinical need, with inflammatory bowel disease (IBD) as their first clinical indication. Alma Bio Therapeutics is led by a seasoned management team with extensive expertise in business development, drug development, and technology commercialization. | Commercial Services |
| Abi-Lab2 LLC |
